Methyclothiazide

甲氯噻嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMethyclothiazide
Drug Alias Name甲氯噻嗪MethyclothiazidumDureticEnduronNSC-110431
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1960/10/21
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Dawnrays Pharmaceutical Co Ltd
Inactive CompaniesAbbvie Inc
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC03AA08
Related LinksWikipediaDrugBankKEGG